VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
V-domain Ig suppressor of T cell activation (VISTA), encoded by the human VSIR gene, is a B7 family checkpoint homologous to the programmed death-Ligand 1 sequence. In gynecologic malignancies, VISTA is abnormally expressed and regulates the tumor immune microenvironment, causing a high upregulation...
Main Authors: | Ren Ran, Chang Xin, Chen Cong, Yu Hao, Han Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2023-12-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2023-0866 |
Similar Items
-
IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
by: Xi-Yang Tang, et al.
Published: (2022-07-01) -
Combined Assessment of Immune Checkpoint Regulator VISTA on Tumor-Associated Immune Cells and Platelet-to-Lymphocyte Ratio Identifies Advanced Germ Cell Tumors with Higher Risk of Unfavorable Outcomes
by: Rafał Pęksa, et al.
Published: (2021-04-01) -
Vista of the Future: Novel Immunotherapy Based on the Human V-Set Immunoregulatory Receptor for Digestive System Tumors
by: Paulina Chmiel, et al.
Published: (2023-06-01) -
VISTA expression and patient selection for immune-based anticancer therapy
by: Alexander S. Martin, et al.
Published: (2023-02-01) -
The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
by: Nour el Imane Issam Salah, et al.
Published: (2023-08-01)